BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33406673)

  • 1.
    Chen SC; Halliday CL; Hoenigl M; Cornely OA; Meyer W
    J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33406673
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study.
    Lao CK; Ou JH; Fan YC; Wu TS; Sun PL
    Mycoses; 2023 Oct; 66(10):923-935. PubMed ID: 37449538
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Seyedmousavi S; Chang YC; Youn JH; Law D; Birch M; Rex JH; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0043421. PubMed ID: 34252298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification.
    Bronnimann D; Garcia-Hermoso D; Dromer F; Lanternier F; ;
    Med Mycol; 2021 May; 59(5):486-497. PubMed ID: 33037432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
    Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
    PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
    Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and accurate identification of Pseudallescheria/Scedosporium species.
    Sitterlé E; Giraud S; Leto J; Bouchara JP; Rougeron A; Morio F; Dauphin B; Angebault C; Quesne G; Beretti JL; Hassouni N; Nassif X; Bougnoux ME
    Clin Microbiol Infect; 2014 Sep; 20(9):929-35. PubMed ID: 24476388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
    Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
    Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France.
    Vignals C; Emmerich J; Begueret H; Garcia-Hermoso D; Martin-Blondel G; Angoulvant A; Blez D; Bruneval P; Cassaing S; Catherinot E; Cahen P; Moluçon-Chabrot C; Chevenet C; Delhaes L; Escaut L; Faruch M; Grenouillet F; Larosa F; Limousin L; Longchampt E; Mellot F; Nourrisson C; Bougnoux ME; Lortholary O; Roux A; Rozenblum L; Puges M; Lanternier F; Bronnimann D
    Emerg Infect Dis; 2024 Jun; 30(6):1077-1087. PubMed ID: 38781681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.
    Marinelli T; Kim HY; Halliday CL; Garnham K; Bupha-Intr O; Dao A; Morris AJ; Alastruey-Izquierdo A; Colombo A; Rickerts V; Perfect J; Denning DW; Nucci M; Hamers RL; Cassini A; Oladele R; Sorrell TC; Ramon-Pardo P; Fusire T; Chiller TM; Wahyuningsih R; Forastiero A; Al-Nuseirat A; Beyer P; Gigante V; Beardsley J; Sati H; Alffenaar JW; Morrissey CO
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935914
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
    Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell dispersion during biofilm formation by
    Mello TP; Barcellos IC; Branquinha MH; Santos ALS
    Curr Res Microb Sci; 2023; 4():100191. PubMed ID: 37229517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive Scedosporium and Lomentosora infections in the era of antifungal prophylaxis: A 20-year experience from a single centre in Spain.
    Álvarez-Uría A; Guinea JV; Escribano P; Gómez-Castellá J; Valerio M; Galar A; Vena A; Bouza E; Muñoz P
    Mycoses; 2020 Nov; 63(11):1195-1202. PubMed ID: 32749009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of auranofin and honokiol as antifungals against
    Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
    Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scedosporium apiospermum and Lomentospora prolificans in lung transplant patients - A single center experience over 24 years.
    Vazirani J; Westall GP; Snell GI; Morrissey CO
    Transpl Infect Dis; 2021 Jun; 23(3):e13546. PubMed ID: 33315292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
    Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
    Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scedosporium and Lomentospora Infections Are Infrequent, Difficult to Diagnose by Histology, and Highly Virulent.
    DeSimone MS; Crothers JW; Solomon IH; Laga AC
    Am J Clin Pathol; 2021 Nov; 156(6):1044-1057. PubMed ID: 34160012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum, and Lomentospora prolificans with lung epithelial cells.
    de Mello TP; Aor AC; Branquinha MH; Dos Santos ALS
    Braz J Microbiol; 2020 Jun; 51(2):427-436. PubMed ID: 31736016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
    Mello TP; Lackner M; Branquinha MH; Santos ALS
    J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies.
    Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
    J Antimicrob Chemother; 2020 Dec; 75(12):3582-3585. PubMed ID: 32856079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.